Due to global uncertainty defensive counters such as pharma are being focused on by both the FII's and the retail investors. Cipla has shown strength in these times. It has broken the resistance levels of Rs 1081.55 but went for a retest and consolidated below it after a second continuation of up trend the prices have closed above the resistance level. As prices move above Rs 1105 with confirmation on smaller time frame of 5 or 15 min charts, a buy can be initiated.